Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chester V Oddis, MD
University of Pittsburgh Department of Medicine/Division of Rheumatology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
54 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital "kaspela" Rheumatology Clinic
Plovdiv, Bulgaria
- Umhat "st. Ivan Rilski"
Sofia, Bulgaria
- Umhat
Stara Zagora, Bulgaria
- University of British Columbia, Dept. of Dermatology and Skin Science
Vancouver, British Columbia, Canada
- Revmatologicky Ustav
Prague, Czechia
- Charite-Universitatsmedizin
Berlin, Germany
- University Hospital Erlangen Nuremberg
Erlangen, Germany
- University Medical Center Goettingen
Göttingen, Germany
- University of Debrecen
Debrecen, Hungary
- University Hospital Policlinico-Vittorio Emanuele
Catania, Italy
- Fondazione Policlinico Universitario A.Gemelli-Irccs
Roma, Italy
- Gunma University Hospital
Gunma, Japan
- Hokkaido University Hospital
Hokkaido, Japan
- Yokohama City University Hospital
Kanagawa, Japan
- Kyoto University Hospital
Kyoto, Japan
- Tohoku University Hospital
Miyagi, Japan
- Osaka University Hospital
Osaka, Japan
- Keio University Hospital
Tokyo, Japan
- Nippon Medical School Hospital
Tokyo, Japan
- Wakayama Medical Hospital
Wakayama, Japan
- Klimed
Bialystok, Poland
- Kliniczny Szpital Wojewodzki Nr 1. Im Fryderyka Chopina Klinika Dermatologii
Rzeszów, Poland
- Klimed
Łomża, Poland
- Inha University Hospital
Incheon, South Korea
- Hanyang University Hospital
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Seoul St. Mary'S Hospital
Seoul, South Korea
- Vall D'Hebron General Hospital
Barcelona, Spain
- Hospital 12 Octubre
Madrid, Spain
- Karolinska University Hospital, Rheumatology Clinic
Stockholm, Sweden
- King'S College Hospital Nhs Foundation Trust
London, United Kingdom
- Honorhealth Neurology
Phoenix, Arizona, United States
- Mayo Clinic
Scottsdale, Arizona, United States
- Attune Health Center
Beverly Hills, California, United States
- Ucla Division of Rheumatology
Los Angeles, California, United States
- Denver Arthritis Clinic
Denver, Colorado, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Mayo Clinic
Jacksonville, Florida, United States
- University of Miami
Miami, Florida, United States
- University of South Florida
Tampa, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2018
- Primary completion
- 31 Mar 2021
- Completion
- 5 Oct 2021
- Last update posted
- 16 Aug 2022
- Registered enrollment
- 176
- Registry id
- NCT03813160
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.